BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Caspi DD, Cink RD, Clyne D, Diwan M, Engstrom KM, Grieme T, Mei J, Miller RW, Mitchell C, Napolitano JG, Nere N, Ravn MM, Sheikh A, Wagaw S, Zhang H. Process development of ABT-450 – A first generation NS3/4A protease inhibitor for HCV. Tetrahedron 2019;75:4271-86. [DOI: 10.1016/j.tet.2019.05.064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Cink RD, Lukin KA, Bishop RD, Zhao G, Pelc MJ, Towne TB, Gates BD, Ravn MM, Hill DR, Ding C, Cullen SC, Mei J, Leanna MR, Henle J, Napolitano JG, Nere NK, Chen S, Sheikh A, Kallemeyn JM. Development of the Enabling Route for Glecaprevir via Ring-Closing Metathesis. Org Process Res Dev 2020;24:183-200. [DOI: 10.1021/acs.oprd.9b00469] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 St-pierre G, Cherney AH, Chen W, Dong X, Dornan PK, Griffin DJ, Houk KN, Lin JB, Osgood S, Silva Elipe MV, Timmons HC, Xie Y, Tedrow JS, Thiel OR, Smith AG. Accelerated Development of a Scalable Ring-Closing Metathesis to Manufacture AMG 176 Using a Combined High-Throughput Experimentation and Computational Modeling Approach. Org Process Res Dev 2021;25:442-51. [DOI: 10.1021/acs.oprd.0c00416] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
3 Zhang W, Li S, Liu H, Zhang Y, Xie H, Peng D, Peng H, Ou Z, Peng Z, Dong W, An D. Development of the Enabling Route for a Novel HCV NS3/4A Inhibitor, Furaprevir. Org Process Res Dev . [DOI: 10.1021/acs.oprd.1c00315] [Reference Citation Analysis]
4 Sheikh AY, Mattei A, Miglani Bhardwaj R, Hong RS, Abraham NS, Schneider-Rauber G, Engstrom KM, Diwan M, Henry RF, Gao Y, Juarez V, Jordan E, DeGoey DA, Hutchins CW. Implications of the Conformationally Flexible, Macrocyclic Structure of the First-Generation, Direct-Acting Anti-Viral Paritaprevir on Its Solid Form Complexity and Chameleonic Behavior. J Am Chem Soc 2021;143:17479-91. [PMID: 34637297 DOI: 10.1021/jacs.1c06837] [Reference Citation Analysis]
5 Slagman S, Fessner W. Biocatalytic routes to anti-viral agents and their synthetic intermediates. Chem Soc Rev 2021;50:1968-2009. [DOI: 10.1039/d0cs00763c] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Hong RS, Mattei A, Sheikh AY, Bhardwaj RM, Bellucci MA, McDaniel KF, Pierce MO, Sun G, Li S, Wang L, Mondal S, Ji J, Borchardt TB. Novel Physics-Based Ensemble Modeling Approach That Utilizes 3D Molecular Conformation and Packing to Access Aqueous Thermodynamic Solubility: A Case Study of Orally Available Bromodomain and Extraterminal Domain Inhibitor Lead Optimization Series. J Chem Inf Model 2021;61:1412-26. [PMID: 33661005 DOI: 10.1021/acs.jcim.0c01410] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]